C-type natriuretic peptide in human coronary atherosclerotic lesions

被引:58
作者
Naruko, T
Ueda, M
vanderWal, AC
vanderLoos, CM
Itoh, H
Nakao, K
Becker, AE
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT CARDIOVASC PATHOL, NL-1100 DE AMSTERDAM, NETHERLANDS
[2] OSAKA CITY UNIV, SCH MED, DEPT PATHOL, OSAKA 545, JAPAN
[3] KYOTO UNIV, GRAD SCH MED, DEPT MED & CLIN SCI, KYOTO, JAPAN
关键词
natriuretic peptides; muscle; smooth; atherosclerosis;
D O I
10.1161/01.CIR.94.12.3103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background C-type natriuretic peptide (CNP) belongs to the natriuretic peptide family and is considered to have regulatory effects on vascular tone and smooth muscle growth. Since these features play a role in atherogenesis, the presence of CNP at such sites was studied. Methods and Results Thirty-three coronary artery segments were harvested at autopsy: 10 normal, with diffuse intimal thickening, and 23 atherosclerotic lesions. Samples were snap-frozen and processed for immunohistochemical staining. For the identification of CNP, a mouse monoclonal antibody (KY-CNP-1) was used. 1A4, EBM-11 (CD68), and von Willebrand factor antibodies were used to stain smooth muscle cells, macrophages, and endothelial cells, respectively. CNP is present in several cell types. Normal arterial segments show CNP-positive endothelial cells. Hypercellular atherosclerotic lesions show distinct CNP positivity of smooth muscle cells and macrophages but a decrease in positivity of endothelial cells. Advanced atherosclerotic lesions contain CNP-positive macrophages, but the smooth muscle cells within the fibrous cap and the surface endothelial cells are almost all CNP-negative. Conclusions These observations suggest that CNP has functional significance in atherogenesis.
引用
收藏
页码:3103 / 3108
页数:6
相关论文
共 35 条
[1]  
BROWN J, 1995, J PHYSIOL-LONDON, V489P, pP139
[2]   ATRIAL NATRIURETIC FACTOR - A HORMONE PRODUCED BY THE HEART [J].
DEBOLD, AJ .
SCIENCE, 1985, 230 (4727) :767-770
[3]   A RAPID AND POTENT NATRIURETIC RESPONSE TO INTRAVENOUS-INJECTION OF ATRIAL MYOCARDIAL EXTRACT IN RATS [J].
DEBOLD, AJ ;
BORENSTEIN, HB ;
VERESS, AT ;
SONNENBERG, H .
LIFE SCIENCES, 1981, 28 (01) :89-94
[4]  
DZAU VJ, 1993, J CARDIOVASC PHARM, V21, pS1, DOI 10.1097/00005344-199321001-00001
[5]   C-TYPE NATRIURETIC PEPTIDE IS A GROWTH INHIBITOR OF RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
FURUYA, M ;
YOSHIDA, M ;
HAYASHI, Y ;
OHNUMA, N ;
MINAMINO, N ;
KANGAWA, K ;
MATSUO, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (03) :927-931
[6]   C-TYPE NATRIURETIC PEPTIDE INHIBITS INTIMAL THICKENING AFTER VASCULAR INJURY [J].
FURUYA, M ;
AISAKA, K ;
MIYAZAKI, T ;
HONBOU, N ;
KAWASHIMA, K ;
OHNO, T ;
TANAKA, S ;
MINAMINO, N ;
KANGAWA, K ;
MATSUO, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (01) :248-253
[7]   NOVEL NATRIURETIC PEPTIDE, CNP, POTENTLY STIMULATES CYCLIC-GMP PRODUCTION IN RAT CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
FURUYA, M ;
TAKEHISA, M ;
MINAMITAKE, Y ;
KITAJIMA, Y ;
HAYASHI, Y ;
OHNUMA, N ;
ISHIHARA, T ;
MINAMINO, N ;
KANGAWA, K ;
MATSUO, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (01) :201-208
[8]   A MONOCLONAL-ANTIBODY TO C-TYPE NATRIURETIC PEPTIDE - PREPARATION AND APPLICATION TO RADIOIMMUNOASSAY AND NEUTRALIZATION EXPERIMENT [J].
HAMA, N ;
ITOH, H ;
SUGA, S ;
KOMATSU, Y ;
YOSHIMASA, T ;
NAKAO, K .
JOURNAL OF ENDOCRINOLOGY, 1994, 141 (03) :473-479
[9]  
HARRISON DG, 1987, CIRC RES, V61, P74
[10]   C-TYPE NATRIURETIC PEPTIDE IMMUNOREACTIVITY IN HUMAN BREAST VASCULAR ENDOTHELIAL-CELLS [J].
HEUBLEIN, DM ;
CLAVELL, AL ;
STINGO, AJ ;
LERMAN, A ;
WOLD, L ;
BURNETT, JC .
PEPTIDES, 1992, 13 (05) :1017-1019